Delivery Order SPE2DB22D2211-SPE2DB24FLZC4
Award Date
10/18/23
Potential Completion Date
10/19/23
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $1,403.33, is for the delivery of Doxepin Hydrochloride 3 mg tablets in 30-count packages. The award is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award, valued at $4,389.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of Doxepin Hydrochloride 3 mg tablets. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of Doxepin HCL 3 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,729.85, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a Firm Fixed Price Delivery Order contract with a completion date of January 12, 2024. The contract was awarded through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $1,833.52 for the supply of 4564479569 - Doxepin HCl 6 mg Tablets. The contract has an ultimate completion date of May 3, 2024 and was awarded on May 2, 2024. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies and pharmaceutical products to military treatment facilities and other federal...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Doxepin HCL 3 MG Tablets in packages of 30. The $1,795.44 contract has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has received numerous federal contracts from DLA to supply pharmaceuticals and medical supplies for military treatment programs and facilities....
This federal contract award, valued at $10,367.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Doxepin HCL 3 mg tablets in quantities of 30s. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves...
This federal contract award is for the delivery of 3mg doxepin hydrochloride tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,057.62 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024, with a completion date of June 26, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Doxepin HCL 3 mg tablets. The fixed-price, firm-fixed delivery order has a ceiling value of $2,261.61 and an ultimate completion date of March 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Doxepin HCL 3 mg tablets. The contract has a ceiling value of $2,467.05 and a period of performance through April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and has no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
This federal contract award, with ID SPE2DX15D6038|SPE2DX24F1ZQ4, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,135.14 delivery order is for Doxepin HCl 3 mg tablets, with a completion date of November 17, 2023. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...